Antisense transcript associated to tumor cells having a T(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells
US6005095A · kind A · utility
137Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 1997 |
| Grant date | Dec 21, 1999 |
| Priority date | — |
| Expiry date | Dec 15, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A chimeric bcl-2/IgH antisense transcript that hybridizes with the pre-mRNA of a hybrid gene in t(14;18) translocated cells. An ODN directed to complement any region of the above mentioned antisense transcript and the use thereof for diagnostic or therapeutic purposes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.